Multicenter, retrospective, observational study to explore treatment pattern of systemic corticosteroids for relapse of non-infectious intermediate and posterior uveitis, and pan-uveitis accompanying with VKH disease or sarcoidosis in daily routine practice. - Multicenter, retrospective, observational study to explore treatment pattern of systemic corticosteroids for relapse of non-infectious intermediate and posterior uveitis, and pan-uveitis accompanying with VKH disease or sarcoidosis in daily routine practice.

AbbVie GK0 个研究点目标入组 157 人开始时间: 2018年4月26日最近更新: 2023年10月17日

适应症

试验速览

published

•Patients who meet either of the following criteria 1.Patients undergoing an ophthalmic operation during the 12-month assessment period from the day on which treatment of target relapse starts. 2.Patients in whom dose reduction or discontinuation of systemic corticosteroids cannot be allowed due to the underlying disease (e.g., treatment of pulmonary lesion associated with sarcoidosis), an immunologic disease, interstitial pneumonia, or other relevant condition during the 12-month assessment period from the day on which treatment of target relapse starts. 3.Patients who received the study drug during the 12-month assessment period from the day on which treatment of target relapse starts

发起方